期刊文献+

个案管理模式对乳腺癌患者内分泌治疗的依从性影响 被引量:1

Effect of Case Management Model on the Compliance of the Endocrine therapy of Patients with Breast Cancer
下载PDF
导出
摘要 目的探究个案管理模式对乳腺癌患者内分泌治疗的依从性影响。方法选取该院2012年5月—2015年5月收治的258例乳腺癌行内分泌治疗的患者,按患者住院的先后顺序随机分成观察组和对照组,各组分别为129例。观察组实行个案管理模式,对照组实行常规护理管理模式,对比两组护理满意度、治疗依从性。结果观察组和对照组的护理满意度、治疗依从性,分别为:91.47%、93.80%VS 67.44%、62.02%,组间比较,差异均具有统计学意义,P<0.05。结论乳腺癌内分泌治疗患者,实行个案管理模式,对于患者治疗的依从性有积极的影响,并可提高患者的护理满意度,促进患者及时主动复查随访。 Objective To study the effect of case management model on the compliance of the Endocrine therapy of patients with breast cancer. Methods 258 cases of patients with breast cancer receiving the endocrine therapy admitted and treated in our hospital from May 2012 to May 2015 were selected and randomly divided into two groups with 129 cases in each, the observation group adopted the case management model, while the control group adopted the routine nursing management model, and the nursing satisfactory degree and treatment compliance were compared between the two groups. Results The differences in the nursing satisfactory degree and treatment compliance between the observation group and the control group had statistical significance by comparison,(91.47%, 93.80% VS 67.44%, 62.02%), P〈0.05. Conclusion The implementation of case management model for patients with breast cancer receiving the endocrine therapy has a positive effect on the treatment compliance of patients, which can improve the nursing satisfactory degree of patients and promote the timely and initiative re-examination and follow-up.
出处 《中国卫生产业》 2016年第30期117-119,共3页 China Health Industry
关键词 个案管理模式 乳腺癌 内分泌治疗 治疗依从性 Case management model Breast cancer Endocrine therapy Treatment compliance
  • 相关文献

参考文献8

二级参考文献60

  • 1黄雪微 王利.癌症患者的信息需求-应否与如何告之癌症诊断.中国心理卫生杂志,2002,15(4):264-264.
  • 2Jemal A, Bray F, Center MM, et al.Global cancer statistics [J]. CA Cancer J Clin,2011,61(2) :69-90.
  • 3M ark opoulos C, Polychronis A, Zobolas V, et al.The effect of exemes- tane on the lipidemic profile of postmenopausal early breast cancer patients: preliminary results of the TEAM Greek sub- study [J]. Breast Cancer Res Treat, 2005,93 ( l ) : 61-66.
  • 4Simon 1t, Latreille J, Matte C, et al. Adherence to adjuvant endo- crine therapy in estrogen receptor-positive breast cancer patients with regular follow-up [ J ]. Can J Surg, 2014,57 ( 1) :26-32.
  • 5Duffy JR, Hoskins LM, Chen MC, et al. Nonpharmacological strate- gies for improving heart failure outcomes in tile emmnunity: a sys- tematic review[ J ]. Nurs Care Qual, 2004,19(4):349-360.
  • 6Chlebowski RT, Gel|er ML. Adherence to endocrine therapy tor breast cancer[J]. Oncolagy,2006,71 (1-2) : 1-9.
  • 7Fisher B, Dignam J, Bryant J, et al. Five versus more than five years of tamoxifen therapy for breast cancer patients with negative lymph nodes and estrogen receptor-pnsitive tumors [J ]. J Natl Cancer Inst, 1996,88(21 ) : 1529-1542.
  • 8Hutchins LF, Green SJ, Ravdin PM, et al. Randonfized, controlled trial of cyclophosphamide, methotrexate, and fluorouracil versus ey- clophosphamide, doxorubiein, and fluorouraeil with and without tamoxifen for high-risk, node-negative breast eancer: treatment re- suits of intergroup protocol INT-0102 [J]. J Clin Oneol, 2005,23 (33) :8313-8321.
  • 9Early breast cancer trialists collaborative group. Tamoxifen for ear- ly breast cancer. An overview of the randomized trials [J ].Lancet, 1993,51 (9114) : 1451-1467.
  • 10Jordan VC, Obiorah I, Fan P, et al. Evolution of long-term adjuvant anti-hormone therapy: consequences and opportunities [J].Breast,2011,20(3): 1-11.

共引文献76

同被引文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部